Jeffrey Paley, Director at Travere Therapeutics, holds 79.66K shares in Avenue Therapeutics (Ticker: ATXI), holds ― shares in Immune Pharmaceuticals (Ticker: IMNPQ), holds 51.66K shares in Travere Therapeutics (Ticker: TVTX). Most recently, Jeffrey Paley Bought ― shares of Avenue Therapeutics on Dec 12, 2018 for an estimated value of 78.50K.